Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Hertlein

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Virulence|February 9, 2018
Towards clinical application of non-invasive imaging to detect bacterial infectionsKnut Ohlsen, Tobias Hertlein
Plos One|June 1, 2013
19F magnetic resonance imaging of perfluorocarbons for the evaluation of response to antibiotic therapy in a Staphylococcus aureus infection modelTobias Hertlein, Volker Sturm, Peter Jakob, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2013
Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection modelsTobias Hertlein, Volker Sturm, Udo Lorenz, et al.
Frontiers in Immunology|July 7, 2022
MRSA Infection in the Thigh Muscle Leads to Systemic Disease, Strong Inflammation, and Loss of Human Monocytes in Humanized MiceSophia Hung, Liane Dreher, Joachim Diessner, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 13, 2019
Antibacterial Evaluation of Novel Substituted Cycloheptaindoles in Staphylococcus and Enterococcus StrainsAndreas Hilgeroth, Kaveh Yasrebi, Sibel Suzen, et al.
Molecules (Basel, Switzerland)|December 14, 2017
Novel Effective Small-Molecule Antibacterials against Enterococcus StrainsKerolos Ashraf, Kaveh Yasrebi, Tobias Hertlein, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Novel Small-Molecule Hybrid-Antibacterial Agents against <i>S. aureus</i> and MRSA StrainsRobin Gehrmann, Tobias Hertlein, Elisa Hopke, et al.
Microbial Pathogenesis|May 1, 2026
Systematic analysis of CHAP domain-containing genes deletion mutants links cell wall architecture to antibiotic susceptibility and pathogenesis in S. aureusArif Luqman, Retina Shrestha, Tobias Hertlein, et al.
Antibiotics (Basel, Switzerland)|November 6, 2019
Novel Small-molecule Antibacterials against Gram-positive Pathogens of <i>Staphylococcus</i> and <i>Enterococcus</i> SpeciesMarius Seethaler, Tobias Hertlein, Björn Wecklein, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Novel Effective Fluorinated Benzothiophene-Indole Hybrid Antibacterials against <i>S. aureus</i> and MRSA StrainsMarius Seethaler, Tobias Hertlein, Elisa Hopke, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Virulence|February 9, 2018
Towards clinical application of non-invasive imaging to detect bacterial infectionsKnut Ohlsen, Tobias Hertlein
Plos One|June 1, 2013
19F magnetic resonance imaging of perfluorocarbons for the evaluation of response to antibiotic therapy in a Staphylococcus aureus infection modelTobias Hertlein, Volker Sturm, Peter Jakob, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2013
Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection modelsTobias Hertlein, Volker Sturm, Udo Lorenz, et al.
Frontiers in Immunology|July 7, 2022
MRSA Infection in the Thigh Muscle Leads to Systemic Disease, Strong Inflammation, and Loss of Human Monocytes in Humanized MiceSophia Hung, Liane Dreher, Joachim Diessner, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 13, 2019
Antibacterial Evaluation of Novel Substituted Cycloheptaindoles in Staphylococcus and Enterococcus StrainsAndreas Hilgeroth, Kaveh Yasrebi, Sibel Suzen, et al.
Molecules (Basel, Switzerland)|December 14, 2017
Novel Effective Small-Molecule Antibacterials against Enterococcus StrainsKerolos Ashraf, Kaveh Yasrebi, Tobias Hertlein, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Novel Small-Molecule Hybrid-Antibacterial Agents against <i>S. aureus</i> and MRSA StrainsRobin Gehrmann, Tobias Hertlein, Elisa Hopke, et al.
Microbial Pathogenesis|May 1, 2026
Systematic analysis of CHAP domain-containing genes deletion mutants links cell wall architecture to antibiotic susceptibility and pathogenesis in S. aureusArif Luqman, Retina Shrestha, Tobias Hertlein, et al.
Antibiotics (Basel, Switzerland)|November 6, 2019
Novel Small-molecule Antibacterials against Gram-positive Pathogens of <i>Staphylococcus</i> and <i>Enterococcus</i> SpeciesMarius Seethaler, Tobias Hertlein, Björn Wecklein, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Novel Effective Fluorinated Benzothiophene-Indole Hybrid Antibacterials against <i>S. aureus</i> and MRSA StrainsMarius Seethaler, Tobias Hertlein, Elisa Hopke, et al.
Pageof 4